Avalon GloboCare Corp. said it entered definitive agreements for a private placement priced at-the-market under Nasdaq rules, selling 6,372,550 shares of common stock or pre-funded warrants, along with Series A-1 and Series A-2 warrants to purchase up to an additional 12,745,100 shares. The securities were offered to accredited investors in an unregistered offering under Section 4(a)(2) and Regulation D at $0.51 per share, with expected gross proceeds of about $3.25 million and up to roughly $6.5 million more if the warrants are fully exercised. H.C. Wainwright & Co. is acting as exclusive placement agent, and the company said it plans to use net proceeds to repay certain debt and for working capital and general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalon Globocare Corp. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.